Advancing our translational research program to improve understanding of the pathophysiology of heart failure unique to children and those with congenital heart disease to become the international leader in discovery, prevention, and treatment of advanced heart failure in children.
Dr. Berger's research focus involves the development of pediatric heart failure and underlying metabolic drivers. He studies how improving metabolic dysregulation may also benefit cardiac dysfunction.
